Lek inaugurates EUR 7.5 million labs in Ljubljana
Ljubljana, 9 September - Pharmaceutical company Lek inaugurated new development laboratories in Ljubljana on Monday in an investment valued at EUR 7.5 million. Among other drugs, they plan to develop sterile solid dosage forms to treat cancer patients.
Ljubljana
The pharma company Lek opens new laboratories in its development centre in Ljubljana, woth EUR 7.5 million.
Photo: Naum Dretnik/STA
Ljubljana
The pharma company Lek opens new laboratories in its development centre in Ljubljana, woth EUR 7.5 million.
Photo: Naum Dretnik/STA
Ljubljana
The pharma company Lek opens new laboratories in its development centre in Ljubljana, woth EUR 7.5 million.
Photo: Naum Dretnik/STA
Ljubljana
The pharma company Lek opens new laboratories in its development centre in Ljubljana, woth EUR 7.5 million.
Photo: Naum Dretnik/STA
Ljubljana
The pharma company Lek opens new laboratories in its development centre in Ljubljana, woth EUR 7.5 million.
Photo: Naum Dretnik/STA
Ljubljana
The pharma company Lek opens new laboratories in its development centre in Ljubljana, woth EUR 7.5 million.
Photo: Naum Dretnik/STA
Ljubljana
The pharma company Lek opens new laboratories in its development centre in Ljubljana, woth EUR 7.5 million.
Photo: Naum Dretnik/STA
Ljubljana
The pharma company Lek opens new laboratories in its development centre in Ljubljana, woth EUR 7.5 million.
Photo: Naum Dretnik/STA
Ljubljana
The pharma company Lek opens new laboratories in its development centre in Ljubljana, woth EUR 7.5 million.
Photo: Naum Dretnik/STA
The rest of this news item is available to subscribers.
The news item consists of 1.701 character (without spaces) or 314 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.